|
|
Observation the clinical effect of Mifepristone combined with Misoprostol in induction of labor in the middle trimester of scar uterus |
AI Dan1 ZHONG Li-zhen2 |
1.Department of Reproductive Health,Jiangxi Maternal and Child Health Care Hospital,Nanchang 330006,China;
2.Outpatient,Jiangxi Maternal and Child Health Care Hospital,Nanchang 330006,China |
|
|
Abstract ObjectiveTo investigate the clinical effect of Mifepristone combined with Misoprostol in induction of labor in the middle trimester of scar uterus.Methods100 induction of labor in the second trimester of scar uterus patients from May 2015 to May 2016 treated in our hospital were selected as objects.Patients were divided into two groups according to lottery method,and each group was 50 cases.The control group and observation group were respectively given treatment of abdominal wall with amniotic Membrane Injection and Mifepristone combined with Misoprostol.Two groups of patients with complications,placental residual rate,bleeding volume,successful rate of induced labor,duration of medication to contractions start time,the contractions to the fetal placental delivery time,delivery time to the fetal placenta were compared.ResultsObservation group of patients with duration of medication to contractions start time [(27.69±3.52)h],the contractions to the fetal placental delivery time[(8.52±1.44)h],delivery time to the fetal placenta[(34.53±3.95)h]were shorter than those in the control group[(35.86±5.86)h,(11.32±2.56)h,(48.91±5.22)h],the differences were statistically significant(P<0.05).Placental retention rate of the patients in observation group(4.00%)was lower than the control group(30.00%),the bleeding volume of the patients in observation group[(142.74±25.98)ml]was less than the control group [(159.86±36.85)ml],the success rate of induced labor (98.00%)was higher than the control group(76.00%),the differences were statistical significance(P<0.05).The incidence of complications in the observation group(2.00%)was lower than the control group(26.00%),and the difference was statistically significant(P<0.05).ConclusionMifepristone combined with Misoprostol in the treatment of induced abortion in the middle trimester of scar uterus can improve the success rate of induced labor and reduce the risk of treatment.
|
|
|
|
|
[1] |
解春燕.米非司酮配伍米索前列醇用于妊娠13~21周瘢痕子宫引产的疗效分析[J].陕西医学杂志,2014,88(12):1689-1690.
|
[2] |
左洁.米非司酮联合米索前列醇终止瘢痕子宫中期妊娠的随机对照研究[J].医学综述,2014,20(10):1893-1895.
|
[3] |
刘晓霞,白云,林晓娟,等.米非司酮分别配伍依沙丫啶、米索前列醇在瘢痕子宫中期妊娠引产中的临床效果比较[J].昆明医科大学学报,2015,36(10):55-58.
|
[4] |
王之珺.米非司酮联合米索前列醇在不同特征瘢痕子宫中期引产中的疗效及安全性分析[J].国际妇产科学杂志,2016,43(4):471-474.
|
[5] |
刘军永.米非司酮配伍米索前列醇用于瘢痕子宫妊娠13~16 周引产的临床观察[J].中国美容医学,2012,21(Z2):301-302.
|
[6] |
冯鑫,徐进芳,徐杰,等.低剂量米索前列醇联合复方米非司酮对中孕期引产的临床效果研究[J].中华妇幼临床医学杂志(电子版),2016,12(6):690-693.
|
[7] |
朱筱丹.米索前列醇不同给药方式终止中期妊娠的临床疗效及安全性研究[J].中国临床药理学杂志,2015,31(22):2220-2222.
|
[8] |
陆少丽,杨臻.顿服米非司酮联合米索前列醇在引产中的应用效果观察[J].广西医学,2016,38(11):1505-1506,1510.
|
[9] |
王海锋,葛丽娟,李晖,等.保妇康栓联合米非司酮及米索前列醇在孕中期引产中的作用[J].陕西中医,2016,37(10):1291-1292.
|
[10] |
钱金凤,王彩燕,诸葛听,等.米非司酮配伍米索前列醇终止16~24周妊娠的临床研究[J].中国计划生育学杂志,2015,23(7):461-464.
|
[11] |
吴华.利凡诺、米非司酮分别配伍米索前列醇用于中期无痛引产的比较研究[J].医学理论与实践,2014,78(16):2184-2185.
|
[12] |
胡淑红.探析米非司酮联合米索前列醇用于高危妊娠引产的效果[J].中国保健营养,2017,27(18):292-293.
|
[13] |
徐嘉,陈玉霞,杨蕊,等.不同引产方法应用于中期妊娠引产的效果观察[J].护理实践与研究,2014,12(9):52-53.
|
[14] |
蔡昱,何川,战媛等.利凡诺、米非司酮联合米索前列醇中期引产的临床效果[J].广西医学,2015,65(9):1328-1330.
|
[15] |
高海玲.米非司酮联合米索前列醇的引产对疤痕子宫患者产程及并发症的影响[J].中国继续医学教育,2015,41(6):213-214.
|
|
|
|